These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4039169)

  • 21. Calcium antagonism in vascular smooth muscle cells.
    Fleckenstein-Grün G
    Pflugers Arch; 1996; 432(3 Suppl):R53-60. PubMed ID: 8994543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From calcium antagonists to calcium antagonism].
    Ferrari R; Visioli O
    Cardiologia; 1985 Jan; 30(1):15-20. PubMed ID: 3896491
    [No Abstract]   [Full Text] [Related]  

  • 25. [Calcium channel blockers].
    Batlouni M
    Arq Bras Cardiol; 1985 Jun; 44(6):423-41. PubMed ID: 3913409
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological basis of the antihypertensive action of calcium entry blockers.
    van Zwieten PA; Timmermans PB
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S11-7. PubMed ID: 2412005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium blockers in smooth-muscle disorders. Current status.
    Schwartz ML; Rotmensch HH; Vlasses PH; Ferguson RK
    Arch Intern Med; 1984 Jul; 144(7):1425-9. PubMed ID: 6375615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel blockers. Is it time to split the lump?
    Materson BJ
    Am J Hypertens; 1995 Mar; 8(3):325-9. PubMed ID: 7794584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonists. Pharmacologic differences and similarities.
    Wood AJ
    Circulation; 1989 Dec; 80(6 Suppl):IV184-8. PubMed ID: 2598454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel blockers in the treatment of disease.
    Elmslie KS
    J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification of Ca antagonist by its chemical structure and characteristics of each derivative].
    Oike M; Xiong ZL; Kuriyama H
    Nihon Rinsho; 1989 Aug; 47(8):1719-27. PubMed ID: 2585734
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental pharmacology of calcium antagonists].
    Godfraind T
    Therapie; 1993; 48 Spec No():637-49. PubMed ID: 8091349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacology of calcium antagonists.
    Wilson TW; Quest DW
    Can J Cardiol; 1995 Mar; 11(3):243-9. PubMed ID: 7889444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcium channel blockers. Review and attempt at classification].
    van Zwieten PA; Timmermans PB
    Rev Esp Cardiol; 1984; 37(5):322-9. PubMed ID: 6387828
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium entry blockers: potential applications in shock.
    Hess ML; Greenfield LJ
    Adv Shock Res; 1983; 10():15-25. PubMed ID: 6349295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.